Prevention and early detection of vascular complications of diabetes

被引：162

作者：

Marshall, Sally M. ^{[1
]}

Flyvbjerg, Allan

机构：

[1] Newcastle Univ, Sch Med, Diabet Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England

[2] Aarhus Univ, DK-8000 Aarhus, Denmark

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2006年 / 333卷 / 7566期

关键词：

D O I：

10.1136/bmj.38922.650521.80

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：475 / 480

页数：14

共 65 条

[11]

Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3

[12] Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials [J].

Costa, Joao ;

Borges, Margarida ;

David, Claudio ;

Carneiro, Antnio Vaz .

BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7550) :1115-1118C

[13] Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA):: a multicentre randomised controlled trial [J].

Dahlöf, B ;

Sever, PS ;

Poulter, NR ;

Wedel, H ;

Beevers, DG ;

Caulfield, M ;

Collins, R ;

Kjeldsen, SE ;

Kristinsson, A ;

McInnes, GT ;

Mehlsen, J ;

Nieminen, M ;

O'Brien, E ;

Östergren, J .

LANCET, 2005, 366 (9489) :895-906

[14] High prevalence of risk factors for cardiovascular disease in parents of IDDM patients with albuminuria [J].

DeCosmo, S ;

Bacci, S ;

Piras, GP ;

Cignarelli, M ;

Placentino, G ;

Margaglione, M ;

Colaizzo, D ;

DiMinno, G ;

Giorgino, R ;

Liuzzi, A ;

Viberti, GC .

DIABETOLOGIA, 1997, 40 (10) :1191-1196

[15]

ELIASSON B, 1996, GAP GUIDELINES RELIT

[16] INSULIN-RESISTANCE AND ABNORMAL ALBUMIN EXCRETION IN NONDIABETIC FIRST-DEGREE RELATIVES OF PATIENTS WITH NIDDM [J].

FORSBLOM, CM ;

ERIKSSON, JG ;

EKSTRAND, AV ;

TEPPO, AM ;

TASKINEN, MR ;

GROOP, LC .

DIABETOLOGIA, 1995, 38 (03) :363-369

[17] Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes [J].

Gaede, P ;

Vedel, P ;

Larsen, N ;

Jensen, GVH ;

Parving, H ;

Pedersen, O .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (05) :383-393

[18] Does the chronic care model serve also as a template for improving prevention? [J].

Glasgow, RE ;

Orleans, CT ;

Wagner, EH ;

Curry, SJ ;

Solberg, LI .

MILBANK QUARTERLY, 2001, 79 (04) :579-+

[19]

Godley PJ, 2005, AM J MANAG CARE, V11, P206

[20] Revealing the cost of Type II diabetes in Europe [J].

Jönsson, B .

DIABETOLOGIA, 2002, 45 (07) :S5-S12

← 1 2 3 4 5 6 7 →